Management of Prediabetes through Darvyadi Ghana Vati

A Clinical Evaluation of Darvyadi Ghana Vati in the cases of Prediabetes under the influence of Deha Prakriti

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/014137

Enrollment

Registered

2018-05-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Prediabetic

Interventions

Intervention1: Group A: Metformin Intervention2: Group B: Darvyadi Ghana Vati 500mg BD Control Intervention1: Group A: Metformin Control Intervention2: Group A: Metformin Control Intervention3: Group

Eligibility

Inclusion criteria

Inclusion criteria: 1.Fasting blood sugar-100-125mg/Dl 2.Postprandial blood sugar-144-199 mg/Dl 3.HbA1C%-5.7-6.5%

Exclusion criteria

Exclusion criteria: Age 60 yrs Fasting BS 125 mg/Dl Postprandial BS 199 mg/Dl Type2 Diabetes Mellitus (NIDDM) with & without complications. Type1 Diabetes Mellitus (IDDM) with or without complication. Diabetes due to endocrinopathies e.g.Pheochromocytoma,Acromegaly,Hyperthyroidism etc. Drug or chemical induced Diabetes Mellitus e.g. Glucocorticoids,Thyroid harmone,Thiazide,Phenytoin etc.

Design outcomes

Primary

Measure	Time frame
Reduced Fasting Blood Sugar,Postprandial Blood Sugar,HbA1C%Timepoint: Assessed at the interval of three months	—

Secondary

Measure	Time frame
Symptoms like Polyphagia, Numbness,Burning sensation improved.Timepoint: Symptoms like Polyphagia, Numbness,Burning sensation improved.	—

Countries

India

Contacts

Public ContactDr Ajai Kumar Pandey

IMS, Banaras Hindu University

drajaipandey@gmail.com9452827885

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026